Female Sexual Health Clinical Study

You may not realize that your lack of sexual desire could be due to a common medical condition that affects many women. Hypoactive Sexual Desire Disorder, or HSDD, is indicated by a decrease or absence of sexual desire that causes personal distress.

After you go through menopause or have your ovaries removed, there’s a decrease in your body’s production of testosterone. Testosterone is not just a male hormone, but actually plays a role in a woman’s sex drive.

The Medical Center for Female Sexuality is a study site for a topical gel that is being tested to see if it raises testosterone levels, and therefore desire, in women. A tiny amount of the product, called LibiGel® , is applied to the skin of the arm once a day to see if testosterone levels increase.

We are screening and monitoring patients in two clinical trial groups:

1. If you are a woman at least 30 years of age, have gone through menopause or had your ovaries removed, and are experiencing a decrease in sexual desire you may qualify for this study.
2. If you are a woman between 30 and 65 years of age and have undergone a hysterectomy prior to natural menopause, and you are currently on a stable dose of estrogen therapy you may qualify for this study.

Volunteering for this study means you’ll have access to investigational medication not available to the general public.

If you think you might qualify for either study, please call us for more information at (914) 328-3700. You must live conveniently close to our Westchester office in order to participate.

LibiGel® Study at MCFS: (914) 328-3700